论文部分内容阅读
目的IAP方案治疗中、晚期非小细胞肺癌的近期疗效及毒、副反应的观察。方法58例中、晚期非小细胞肺癌,其中初治35例,复治23例。结果IAP方案治疗非小细胞肺癌总有效率为50%,初治病例有效率为57.1%,复治病例有效率为39.1%。结论IAP方案治疗中、晚期非小细胞肺癌疗效较佳,用药安全,可做为一线及复治患者二线方案用药。
Objective IAP regimen in the treatment of advanced non-small cell lung cancer in the short term efficacy and toxicity, side effects observed. Methods 58 cases of advanced non-small cell lung cancer, of which 35 cases of initial treatment, retreatment in 23 cases. Results The total effective rate of IAP regimen in treatment of non-small cell lung cancer was 50%, the effective rate of initial treatment was 57.1%, and the effective rate of retreatment was 39.1%. Conclusion IAP treatment of advanced non-small cell lung cancer better efficacy, medication safety, can be used as first-line and re-treatment of patients with second-line regimen.